Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience.
OBJECTIVE
Laparoscopic myotomy is the currently preferred treatment for achalasia. Our objectives were to assess the long-term outcome of this operation and preoperative factors influencing said outcome.


METHODS
Demographic and clinical characteristics and data on long-term outcome were prospectively collected on patients undergoing laparoscopic myotomy for achalasia at our institution from 1992 to 2007. Treatment failure was defined as a postoperative symptom score higher than the 10th percentile of the preoperative score (>9). Logistic regression analysis was used to identify independent preoperative factors associated with successful myotomy.


RESULTS
Four hundred seven consecutive patients (220 men, 187 women) underwent the laparoscopic Heller-Dor procedure during the study period; 89 (22%) of them had previously had endoscopic treatment(s). The mortality rate was 0; the conversion and morbidity rates were 1.5% and 1.9%, respectively. The operation failed in 10% of patients (39/407) and the 5-year actuarial probability of being asymptomatic was 87%. Most failures (25/39, 64%) occurred within 12 months of the operation and can be considered as technical failures (incomplete myotomy). Pneumatic dilation overcome the dysphagia in 75% of patients whose surgery was unsuccessful. Considering both the primary surgery and this ancillary treatment, the operation was effective in 97% of achalasia patients. The frequency of sigmoid esophagus, lower esophageal sphincter (LES) resting pressures, and chest pain scores differed statistically between patients with and without recurrences. At multivariate analysis, high preoperative LES pressures (>30 mm Hg) was an independent predictor of a good response. The presence of chest pain and of sigmoid esophagus independently predicted the failure of the procedure.


CONCLUSIONS
Laparoscopic myotomy can durably relieve dysphagia symptoms. High preoperative LES pressures represent the strongest predictor of a positive outcome, probably reflecting a less severely damaged esophageal muscle.
Zaninotto
Giovanni
G
Department of General Surgery, S Giovanni e Paolo Hospital, Venice, Italy. giovanni.zaninotto@unipd.it
Costantini
Mario
M
Rizzetto
Christian
C
Zanatta
Lisa
L
Guirroli
Emanuela
E
Portale
Giuseppe
G
Nicoletti
Loredana
L
Cavallin
Francesco
F
Battaglia
Giorgio
G
Ruol
Alberto
A
Ancona
Ermanno
E
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004106:Dilatation; D004931:Esophageal Achalasia / Q000503:physiopathology / Q000601:surgery*; D005260:Female; D018662:Fundoplication; D006801:Humans; D010535:Laparoscopy; D016015:Logistic Models; D008297:Male; D008365:Manometry; D008875:Middle Aged; D015999:Multivariate Analysis; D009465:Neuromuscular Agents / Q000008:administration & dosage; D011183:Postoperative Complications / Q000453:epidemiology; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A